NACO & HIV control National Program in India

On AIDS national programme

1. NACP

2. NACP National AIDS Control Program

3. NACO's Vision and Commitment

4. NACO’s Approach

5. NACO’s Goals

6. HISTORY

7. NACP II

8. NACP III

9. SACS and DAPCUs

10. NACP IV

11. NACP IV

12. Component 1 - Prevention Services

13. Component 2 - IEC Services

14. Component 3 - Comprehensive Care and Treatment

15. Component 4 - Strengthening Institutional Capacities

16. Component 5 - Strategic Information Management Systems (SIMS)

17. NACP V

18. HIV and AIDS (Prevention & Control) Act, 2017

19. India’s HIV/AIDS Prevention and Control Act, 2017

20. HIV

21. RISK FACTORS

22. Transmission

23. Diagnosis of HIV in Adult and Children

24. Diagnosis

25. Diagnosis of HIV infection in adults and children above the age of 18 months

26. Testing Strategy

27. Screening (For Blood Banks & HCTS Screening Facilities)

28. Surveillance (II A) ( For Surveillance)

29. Algorithm II (B)(For diagnosis of clinically symptomatic individual)

30. Algorithm III (For diagnosis of clinically asymptomatic patient)

31. National Testing Algorithm for HIV-1 exposed infants and children below the age of 18 months

32. Assessment of Adults and Adolescents with HIV Infection

33. Principles of ART

34. When to Start ART in Adults and Adolescents

35. What to Start: Antiretroviral Therapy Regimens

36. Recommended Choice of First-Line Regimen

37. Opportunistic infections and HIV-related conditions and ART initiation

38. Cotrimoxazole Preventive Therapy Cotrimoxazole: (Sulfamethoxazole–Trimethoprim [SMX–TMP])

39. CPT

40. PPTCT and ART in Pregnant Women

41. Post Exposure Prophylaxis The first dose of PEP should be administered ideally within 2 hours (but certainly within the first 72 hours) of exposure and the risk evaluated as soon as possible